These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2871857)

  • 1. The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.
    Alabaster VA; Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):9S-17S. PubMed ID: 2871857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA; Reid JL; Vincent J
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of differential inhibition by nifedipine of pressor responses induced by alpha 1- and alpha 2-adrenoceptor agonists and by angiotensin II in anaesthetized cats.
    Alabaster VA; Solca AM
    Clin Sci (Lond); 1985; 68 Suppl 10():73s-75s. PubMed ID: 2857622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
    Dunn WR; McGrath JC; Wilson VG
    Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 2-adrenoceptor agonists potentiate responses mediated by alpha 1-adrenoceptors in the cat nictitating membrane.
    Shepperson NB
    Br J Pharmacol; 1984 Oct; 83(2):463-9. PubMed ID: 6148985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into interactions between doxazosin and enalaprilat at alpha 1-adrenoceptors in anaesthetized rats.
    Marwood J; Tierney G; Stokes G
    Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):231-6. PubMed ID: 1676939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
    Drew GM; Whiting SB
    Br J Pharmacol; 1979 Oct; 67(2):207-15. PubMed ID: 40647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
    Elliott HL; Meredith PA; Sumner DJ; McLean K; Reid JL
    Br J Clin Pharmacol; 1982 May; 13(5):699-703. PubMed ID: 6123342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacological studies with doxazosin.
    Elliott HL; Meredith PA; Vincent J; Reid JL
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):27S-31S. PubMed ID: 2871854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1983 Jun; 15(6):719-25. PubMed ID: 6135439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro study of interactions between doxazosin and enalaprilat at vascular alpha 1-adrenoceptors.
    Tierney G; Marwood J; Stokes G
    Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):329-32. PubMed ID: 2568203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoceptor mechanisms in epinephrine-induced anterior choroidal vasoconstriction in cats.
    Koss MC
    Exp Eye Res; 1994 Dec; 59(6):715-22. PubMed ID: 7698264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.
    Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
    J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J; Docherty JR
    Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentolamine lacks alpha 2-adrenoceptor agonist activity in anaesthetized dogs.
    Bell C
    Br J Pharmacol; 1988 Feb; 93(2):337-40. PubMed ID: 2896034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.